DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAD3. A total of 11 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,509,030
-46.9%
22,000,000
-31.2%
0.39%
-45.2%
Q2 2023$33,000,928
-9.1%
32,000,0000.0%0.70%
-12.9%
Q1 2023$36,310,720
+15.8%
32,000,0000.0%0.81%
+24.7%
Q4 2022$31,357,440
-16.5%
32,000,0000.0%0.65%
-13.2%
Q3 2022$37,558,000
+12.3%
32,000,0000.0%0.75%
+8.4%
Q2 2022$33,439,00032,000,0000.69%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 28,000,000$22,338,5401.31%
DeepCurrents Investment Group LLC 19,901,000$16,080,8040.70%
CSS LLC/IL 13,245,000$10,542,8220.69%
Context Capital Management, LLC 9,000$7,1590.57%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 22,000,000$17,509,0300.39%
LINDEN ADVISORS LP 43,274,000$34,466,0260.35%
READYSTATE ASSET MANAGEMENT LP 8,227,000$6,561,0330.33%
WHITEBOX ADVISORS LLC 11,500,000$9,113,7500.29%
III Capital Management 5,000,000$3,983,0250.20%
Opti Capital Management, LP 3,000,000$2,3940.17%
View complete list of PTC THERAPEUTICS INC shareholders